ProNova Solutions and medPhoton announced today that they have agreed to form an exclusive partnership that will merge leading edge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market.
“Together we feel that this unique solution will enable clinicians to develop advanced proton therapy protocols for Adaptive Therapy.”
ProNova will integrate the medPhoton ImagingRing system into the SC360 proton therapy solution. The resulting system will include Fast Scanning IMPT technology with integrated 3D imaging. This unique solution merges leading edge pencil beam delivery, innovative dual-energy 3D imaging capability and precision positioning to aid physicians and therapists in minimizing collateral damage to healthy tissue and maximizing dose to the tumor. The ProNova compact superconducting gantry design allows for 360 degrees of patient treatment angle and improved workflow, resulting in faster treatment times and higher productivity.
medPhoton´s newly developed ImagingRing system is a slim, couch based, in-room CBCT device, capable of large field of view, low dose, single source dual energy 3D volumetric and 2D planar image acquisitions. It supports smooth workflows and highest precision in inter- and intrafractional image guided radiotherapy.
“medPhoton is glad that our hard research and development work over the last years will now have a real impact on the field. After having installed our first unit at the carbon beam facility MedAustron, we will now integrate our slim imaging ring system with ProNova’s cutting edge small footprint proton therapy equipment. In combination of both systems, precise beam adaptation and tracking of moving targets will be possible in the near future. A series of joint installations, research and clinical, has been ordered,” says Heinz Deutschmann, chief executive officer and founder of medPhoton.
“ProNova is proud to partner with an innovative company like medPhoton,” said Joe Matteo, Division President of ProNova Solutions, R&D and manufacturing told TechSupport journal. “Together we feel that this unique solution will enable clinicians to develop advanced proton therapy protocols for Adaptive Therapy.”
The new ProNova SC360 system will be on display in Booth #637 at ASTRO’s 56th Annual Meeting being held at the Moscone Center in San Francisco, CA. This year’s meeting will highlight many of the advances in proton therapy, including the need for continued innovation in imaging capability and positioning accuracy.